Multisegmented esophageal fully covered self-expandable metal stent for palliation of malignant dysphagia: a prospective, multicenter feasibility and safety study

A novel multisegmented esophageal fully covered self-expandable metal stent (FCSEMS) was designed to reduce stent migration, which is seen in up to 30% of patients. The goal of this study was to evaluate the safety and efficacy of the multisegmented FCSEMS. This multicenter prospective study aimed t...

Full description

Saved in:
Bibliographic Details
Published in:Gastrointestinal endoscopy 2024-06, Vol.99 (6), p.1027-1031.e6
Main Authors: Koggel, Lieke M., Reijm, Agnes N., Lantinga, Marten A., de Jong, Dirk J., Rodrigues-Pinto, Eduardo, Spaander, Manon C.W., Siersema, Peter D.
Format: Article
Language:English
Subjects:
Aged
Aged, 80 and over
Deglutition Disorders - etiology
Deglutition Disorders - therapy
Esophageal Neoplasms - complications
Feasibility Studies
Female
Humans
Male
Middle Aged
Palliative Care - methods
Prospective Studies
Self Expandable Metallic Stents - adverse effects
Treatment Outcome
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A novel multisegmented esophageal fully covered self-expandable metal stent (FCSEMS) was designed to reduce stent migration, which is seen in up to 30% of patients. The goal of this study was to evaluate the safety and efficacy of the multisegmented FCSEMS. This multicenter prospective study aimed to include 30 patients undergoing palliative stent placement. Efficacy, defined as technically successful stent placement and dysphagia scores, and safety, defined as the number of adverse events (AEs) and serious AEs (SAEs), were measured. The study was prematurely terminated due to safety concerns after including 23 patients (mean ± standard deviation age, 72 ± 10 years; 78% male). Stent placement was technically successful in 21 patients (91%), and dysphagia scores had improved in all patients with successful stent placement. SAEs were reported in 16 (70%) patients. Stent-related mortality occurred in 3 patients (13%). The multisegmented FCSEMS successfully treated malignant dysphagia. The study was prematurely terminated, however, because stent placement was associated with a relatively high SAE rate. (Clinical trial registration number: NCT04415463.)
ISSN:0016-5107
1097-6779
1097-6779
DOI:10.1016/j.gie.2024.01.045